AI SoCs Boost Ambarella Revenue ~50%; Heavy R&D and Stock Compensation Keep Losses

Ambarella, Inc. (NASDAQ: AMBA) - quick read: the business is scaling revenue fast as AI inference SoCs gain traction, but the company is still running large R&D and compensation expenses that keep it loss-making despite improved operating performance and healthy liquidity.

What's happening inside the company

- Management is investing heavily in product and AI chip development: R&D is growing (three months ended 7/31/2025: $59.7M; six months: $118.6M) and chip development & tools spending increased materially year-over-year.

- Employee compensation and equity programs are significant drivers of expense and dilution: stock-based compensation was $25.2M for the quarter and $51.3M for six months; $137.5M of unrecognized RSU expense remains (weighted avg. vesting 2.23 years).

- Operational cash generation turned meaningfully positive: net cash provided by operating activities was $20.3M (six months) versus $1.8M prior year.

- Capital allocation: Board extended share repurchase program; 24,152 shares repurchased for ~$1.0M in the six months and ~$48.0M remains available through 6/30/2026.

- Customer & supply concentration remains a core operational risk: WT Microelectronics accounted for ~71.3% of revenue for the three months ended 7/31/2025 and ~67.4% for the six months; key foundry reliance on Samsung and third-party assembly/test continues.

Key numbers and facts (as reported)

- Revenue: $95.511M (Q) / $181.383M (six months) - +49.9% / +53.5% vs prior-year periods.

- Gross profit: $56.231M (Q) / $107.767M (six months); gross margin ~58.9% (Q) and 59.4% (six months), down from 60.8% last year.

- Operating expenses: R&D $59.734M (Q) and SG&A $18.486M (Q); total operating expenses $78.220M (Q).

- Operating loss: $(21.989)M (Q) vs $(36.287)M prior-year Q - improvement driven by higher revenue but still negative.

- Net loss: $(19.995)M (Q) / $(44.323)M (six months); diluted EPS $(0.47) (Q) / $(1.05) (six months).

- Other income, net ~ $2.247M (Q) - modest contribution from investment yields.

- Cash & equivalents: $142.739M; marketable debt securities: $118.444M - total cash & marketable securities ≈ $261.2M as of 7/31/2025.

- Total assets: $706.431M; shareholders' equity: $576.520M; goodwill: $303.625M; intangible assets (net): $41.879M.

- Accounts receivable: $42.896M (up vs $29.767M at 1/31/2025); inventories: $33.808M.

- Deferred revenue (current): $19.482M; remaining unsatisfied performance obligations: ~$39.2M (≈81% expected within 12 months).

- Manufacturing purchase commitments: $69.3M (7/31/2025).

- Shares outstanding: 42,674,711 (issued & outstanding at 7/31/2025); 42,689,006 outstanding as of 8/31/2025 (disclosed).

Positive aspects of the income statement

- Strong revenue growth: nearly +50% QoQ YoY (Q) and +53.5% for six months - clear demand acceleration for higher‑ASP AI inference processors and NRE services.

- Higher gross profit and improved operating loss vs prior-year periods: operating loss narrowed ($22M vs $36M prior-year quarter).

- Positive operating cash flow ($20.3M six months) indicates improving core cash generation despite GAAP losses.

- Interest/other investment income is steady, supporting non-operating cash inflows.

Negative aspects of the income statement

- Company remains loss-making on a GAAP basis: net loss $(20)M Q and $(44.3)M six months - large recurring R&D and compensation costs keep losses material.

- R&D is very large relative to revenue (R&D ≈ 63% of revenue in the quarter), pressuring operating leverage until higher-margin products scale.

- Stock-based compensation is a sizable recurring non-cash expense ($25.2M Q) and will continue to pressure reported results and dilution.

- Gross margin erosion (down ~1.4-1.9 ppt) tied to higher manufacturing costs for advanced process technologies and inventory mix - margin recovery depends on cost and yield improvements.

- Extreme customer concentration (WT >70% of Q revenue) amplifies revenue volatility and collections risk.

Bottom line / quick take

- Ambarella is executing a high-investment growth strategy: product mix is shifting toward higher‑ASP AI inference SoCs and NRE services, producing strong revenue growth and better operating leverage relative to last year.

- However, the company is still investing ahead of revenue recognition - R&D and stock comp keep GAAP losses sizable and create dilution risk. Customer concentration and third‑party manufacturing dependency remain material operational risks.

Watch for next catalysts: sustained quarter-to-quarter revenue growth with margin recovery, steady operating cash flow expansion, reduction in customer concentration, and manufacturing yield/cost improvements.